Archive for the ‘Kraig Biocraft Laboratories Inc. KBLB’ Category

Recognizing New Development Opportunities in Micro-Cap Stocks

Wednesday, September 2nd, 2009

Understanding the minds of innovative people as well as working to develop new concepts, products and/or ideas is a difficult process in any environment. Mesh this with trying to develop a profitable Micro-Cap company and the investment process becomes quite a bit more “interesting.” There are, however, certain signs in a developing Micro-Cap to keep an eye out for. First among these is “variation and adaptability.” Being able to have access to sources of information that can spot these subtleties is the key, but understanding that a company is working in this mode is the real deal.

To demonstrate, consider Kraig Biocraft Laboratories (KBLB.OB). This small developmental bio company started with a polymer insertion process that allows for the generation of spider silk, a material with exceedingly strong physical properties. In this regard, however, the process was also found to hold other opportunities for additional properties to be added to the basic medium of the polymer. With the advent of stem cells and other basic materials being able to be added to the process, Kraig Biocraft recognized the possible variations and profit opportunities.

It is not rocket science, but understanding the process of development and the ability to see companies that work with this in mind is the key to solid Micro-Cap profit opportunity. In a general way, starting with a basic concept is the beginning, but working that concept forward is the real profit potential.

Let us hear your thoughts below:

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Exceeds Goal for DNA Insertions

Tuesday, September 1st, 2009

Kraig Biocraft Laboratories Inc. is a biotech company working to develop and commercialize high performance polymers. The company intends to break into the $92 billion market for high performance fibers by using spider silk genes.

The company intends to insert these genes into silkworms to make them produce fibers with the characteristics of spider silk, which is one of the strongest natural fibers known. In an effort to reach these goals, Kraig Biocraft has licensed the spider gene sequences patented by the University of Wyoming and the genetic developed technology by the University of Notre Dame.

Several weeks ago, Kraig Biocraft announced that during the months of May, June and July the scientific team succeeded in its previously announced attempt to ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. In May itself, the rate of DNA construct insertions were twice the number of insertions that had been performed to date.

The genetic constructs are DNA packets that act as a blueprint for the creations of new polymers and proteins based on spider silk. Every targeted DNA construct insertion has the potential to create a new fiber with commercial applications. Kraig Biocraft was very pleased to report that the actual number of insertions performed greatly exceeded the company’s target and that the increase in insertions was sustained through the months of June and July as well.

Kraig Biocraft CEO Kim K. Thompson commented on the success of the company’s scientific team, which is led by Dr. Malcolm J. Fraser. He said, “Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period. This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists.”

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Focused on Entering the $92 Billion Market for High-Performance and Technical Fibers

Thursday, August 27th, 2009

Kraig Biocraft Laboratories, Inc., a biotechnology company focused on the development of commercially significant polymers and high performance fibers, invests in genetic research and targeted product development to create innovative near-term solutions to meet the practical problems of our world. The company is currently working in cooperation with university scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace for high-performance polymers.

Kraig Biocraft Laboratories develops collaborative relationships with leading universities and funds university scientists and laboratories to create technologies with significant commercial applications through the Kraig Research Initiative. As a part of this program, the company has licensed university intellectual property in the fields of genetics and genetic engineering.

The company sponsors and collaborates on research within various universities’ genetic engineering laboratories. In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time, the company has been a proud sponsor of scientific research and development within the university.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Continues To Grow Its Intellectual Property Portfolio

Monday, August 24th, 2009

Kraig Biocraft Laboratories, Inc., the Michigan-based company using genetic engineering to allow silkworms to produce spider silk, is making use of some of the most advanced insect-related genetic engineering techniques known. Scientists have already produced the first transgenic silkworms, and other scientists have discovered the sequence of genes used by spiders to produce silk. The brilliance of Kraig’s approach is the bringing together of researchers from both of these fields in a collaborative effort to produce commercially viable quantities of spider silk.

Kraig Biocraft has acquired the exclusive rights in this field to the genetic sequences patented by the University of Wyoming, and the genetic engineering technology developed by the University of Notre Dame. The company is now working in conjunction with the leading genetic scientists at these universities to produce a transgenic variety of silkworm capable of producing the elusive spider silk.

The process is tedious and exacting, but the goal could be worth tens of billions of dollars. Spider silk exceeds all known fibers in its ability to absorb energy without breaking. This makes it a potential super fiber for a host of ballistic resistant, medical, industrial, and even fashion related applications. Discovering a way to make such silk commercially viable would be a major scientific achievement, of exceeding value to companies like DuPont that currently dominate the technical textiles market.

As part of the company’s intellectual property portfolio, Kraig Biocraft has the exclusive rights to use the patented spider silk gene sequences in silkworms within the United States. The company’s intellectual property portfolio also includes a separate U.S. provisional patent application for certain methodologies, genetic sequences, organic polymers, and composites of fibers.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) is Excited about Spider Silk

Tuesday, August 18th, 2009

Kraig Biocraft Laboratories Inc. is an emerging biotech company with a strong intellectual property portfolio relating to genetic modification of silkworms to produce spider silk. The company believes this path of research will lead to the development of a new “super fiber” such as Kevlar. The total market for such fibers is believed to be about $90 billion annually.

Kraig Biocraft has reason to be excited about spider silk. The silk produced by spiders is among the strongest fibers produced in nature. Spider silk is also extremely elastic and resilient. Depending upon how measurements are made, spider silk is nearly as strong, or in some cases even stronger, than steel or Kevlar.

Spider silk has several properties that are unmatched even by the most exotic of man-made fibers. Spider silk has the unbeatable capacity to absorb energy and to dissipate this energy in a very controlled manner. This unique property makes this fiber especially attractive for applications where energy absorption is a key design factor.

Another significant property of spider silk is its extreme resistance to breaking under strain. In this area, it outperforms virtually ALL known natural and synthetic fibers. If Kraig Biocraft’s research is successful and they are able to produce a spider silk product, it may well be a real money-maker for the company. Estimates are that such a product may immediately be worth from several hundred million dollars to as high as one billion dollars. A 2% penetration of the “super fiber” market would likely be worth in excess of $3 billion.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) on the Verge of Unlocking New Markets

Thursday, August 13th, 2009

Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working directly in conjunction with leading genetic engineers at these universities to develop transgenic silkworms.

Kraig Biocraft’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. The company expects this intellectual property portfolio to expand over the coming years.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Very Pleased With its Progress

Wednesday, August 12th, 2009

Kraig Biocraft Laboratories, Inc., the Michigan-based company pioneering the use of genetic engineering to produce spider silk, recently announced that, during the months of May, June, and July, their scientific team succeeded in its goal to scale up the number of genetic insertions performed. The company has developed an efficient way to insert into silkworms the genetic material used by spiders to produce silk, with the goal of getting silkworms to produce commercially viable spider silk.

The team, led by Malcolm J. Fraser, Ph.D., had an initial goal of doubling the number of DNA construct insertions performed in May. As it turned out, the actual number of insertions performed greatly exceeded that goal, and the increase was sustained in June and July as well. Dr. Fraser heads the Fraser Laboratory at the University of Notre Dame where much of the research is being done.

Kraig’s CEO, Kim Thompson, commented on the unexpected achievement. “Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period. This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”

Since Kraig Biocraft first obtained the right to use the spider silk gene sequence in this particular field of research, they have significantly improved the insertion process. Their approach is a unique protein expression system that is potentially highly scalable and cost effective in producing a variety of proteins that can be marketed to the pharmaceutical and fibers markets, although spider silk remains the primary goal of the company. The company has successfully inserted into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk, but work remains to be done for the actual commercial production of spider silk.

Spider silk is, by weight, much stronger than steel, with a much greater ability to absorb and dissipate energy. This strength to weight ratio promises a wide range of applications, and a huge commercial market.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories Inc.’s (KBLB.OB) Unique Corporate Goals

Thursday, August 6th, 2009

Kraig Biocraft Laboratories Inc. is a cutting edge biotechnology company that is focused on the development of high performance fibers and polymers by creating transgenic silkworms inserted with spider genes. The goal is that these transgenic silkworms will spin a new “super fiber” similar to natural spider silk.

Spider silk is one of the strongest and most resilient fibers known. It has several properties that are unmatched by synthetic fibers. One property is spider silk’s ability to absorb energy and then dissipate the energy evenly. Another property is spider silk’s extreme resistance to breaking under strain. In this respect, spider silk outperforms all known fibers – natural and man-made. It is these properties that make spider silk especially attractive in applications for use in products such as bulletproof vests, artificial limbs, suspension cables and parachute cords.

Kraig Biocraft has acquired the exclusive rights to the genetic sequences for spiders patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working together with the leading genetic engineers at these universities to develop enzymes and strategies for conducting site specific genetic recombination of the spider silk gene in an effort to produce a transgenic variety of silkworm.

Efforts to produce the desired proteins in a transgenic silkworm have significantly accelerated during the course of the year, possibly leading to a breakthrough by the end of 2009. Kraig Biocraft has been able to make 5000+ insertions of genetic packets per week. The company reached a milestone in May with the announcement of the creation of eight spider silk-based genetic constructs. The genetic constructs are packets of DNA that act as a blueprint for the creation of new polymers and spider silk-based proteins.

If Kraig Biocraft is successful in creating a spider silk-based fiber product, the company will be breaking into the huge $90 billion global market for high performance technical fibers. The United States market (where Kraig Biocraft will have their patents) for these fibers is roughly $45 billion. This industry has experienced significant growth over the past decade and growth is expected to continue in the industry for the foreseeable future.

Estimates have been made that any product produced by the company should immediately be worth several hundred dollars in revenues. Spider silk’s unqiue advantages – resistance to breakage and energy absorption – along with the fact that it is a natural product and not produced using toxic chemicals should allow Kraig Biocraft to easily find a profitable niche within the massive fibers industry.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Announces Substantial Increase in Number of Insertions

Monday, August 3rd, 2009

Kraig Biocraft Laboratories, Inc. was pleased to announce this morning that during the months of May, June and July the scientific team achieved its previously announced goal to significantly ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. However, the actual number of insertions performed greatly exceeded that goal and the increase was sustained in June and July as well.

“Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period,” stated CEO Kim K. Thompson. “This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Aims to Turn Spider Silk into a Commercially Available ‘Super Fiber’

Friday, July 31st, 2009

Kraig Biocraft Laboratories Inc. is a biotechnology company using state-of-the-art genetic techniques to develop transgenic silkworms capable of producing spider silk. The company believes that because of spider silk’s characteristics, it has the potential to become a ‘super-fiber’ with many commercial applications.

Spider silk is among the strongest fibers produced in nature. The silk has several properties that are unmatched by man-made fibers. One property is spider silk’s capacity to absorb energy and to dissipate this energy in a controlled manner. This property makes spider silk especially attractive for applications where energy absorption is a key design factor such as bulletproof vests, suspension cables, parachute cords, artificial ligaments, etc.

Another significant property of spider silk is its extreme resistance to breaking under strain. In this respect, spider silk significantly outperforms virtually all known natural and man-made fibers. It is this property that makes spider silk appealing for use as a ‘super fiber’.

With spider silk products, Kraig Biocraft will be attempting to break into the market for high performance technical fibers. This market generates $90 billion per year, with the United States accounting for more than half of the market. The industry has experienced significant growth over the past 10 years and growth in the sector is expected to continue.

There are well-established products in the marketplace – Kevlar, Spectra, Dyneema – which will provide competition for the company’s products. However, there are certain properties that are inherent to spider silk, such as the ability to absorb energy, making it superior to these synthetic products.

Spider silk, being all natural, should also give Kraig Biocraft an advantage over competitors’ products which are made in a manufacturing process using toxic chemicals and are highly pollutive to the environment. Based on these factors, the company should be able to find a profitable niche for their products in the marketplace.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Leveraging Their Research into Spider Silk

Wednesday, July 22nd, 2009

Kraig Biocraft Laboratories Inc. is a biotechnology development company focused on genetically engineered high performance polymers and technical fibers. The company is currently working on research to genetically coax silkworms into producing spider silk.

Kraig Biocraft believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications. The overall marketplace for these types of fibers in general is approximated to be $90 billion. According to Emerging Growth Research, an independent industry research firm, if Kraig Biocraft is successful is achieving its goal and producing a spider silk fiber product, “the technology will likely immediately be worth at least several hundred million dollars.”

In order to reach its goal, Kraig Biocraft has leveraged its efforts by working cooperatively with select university laboratories. This arrangement allows the company to bring technologies from diverse research institutions and combine them.

As part of this strategy, Kraig Biocraft licenses university intellectual properties in genetics and genetic engineering, thus allowing them to tap some of the greatest minds in the field. To date, the company has licensed technology from the University of Wyoming and the University of Notre Dame.

The genetic technology involved is very complex. In order to have silkworms produce spider silk, scientists had to develop the technology to successfully insert into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk.

Since the company first obtained the right to use the spider silk gene sequence from the University of Wyoming, Kraig Biocraft has surprised many with the speed of the advances they’ve made. Kraig Biocraft now performs thousands of ‘insertions’ in a single week. This work is occurring at the company’s research program at the University of Notre Dame where substantial progress is being made in the successful insertion of DNA packets, both with the number and proportion of insertions.

As Kraig Biocraft’s success with insertions increases, so does the company’s chance of developing a viable multi-million dollar product.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Assembles Strong Advisory Board

Monday, July 20th, 2009

Kraig Biocraft Laboratories, Inc., the biotech company known for its pioneering work in genetic engineering for the production of spider silk and other polymers, is constantly breaking new ground in the field of genetics. As such, it is not surprising that they have assembled a remarkable team of scientific advisors to play a major role in everything they do.

• Malcolm J. Fraser, Jr., Ph.D, specializes in molecular genetics, and currently heads the Fraser Laboratory at the University of Notre Dame. During his post-doctoral work at Texas A&M, Dr. Fraser was part of the team which developed the genetic expression system for producing organic molecules, including pharmaceuticals, on an industrial scale. He is the co-inventor of the “piggyBac” gene splicing technology, and the named inventor for various patents involving its improvement.

He was recently selected as a fellow of the American Association for the Advancement of Science, in recognition for his distinguished contributions to genetics and transgenesis, as well as for his discovery of the piggyBacs transposable element and derived transgenic vector system.

Dr. Fraser was also awarded $2.5 million from the Bill and Melinda Gates Foundation to fund “deliverable technologies” in the field of transgenesis for the prevention of mosquito born disease.

• Randy Lewis, Ph.D., is internationally renowned for his work on spider silk, and is the named inventor for a number of patents relating to spider silk polymers. He currently heads the Lewis Laboratory at the Department of Molecular Biology at the University of Wyoming, where he focuses on the underlying genetics of spider silk polymers.

• Donald L. Jarvis, Ph.D., is an expert on biosynthesis, and its practical genetic engineering applications. He has many patent applications and intellectual property licensing agreements involving biosynthesis technologies with potential applications for pharmaceutical production. He currently heads a research laboratory in the Department of Molecular Biology at the University of Wyoming.

The strength of this advisory board is one of the reasons Kraig Biocraft has gained recognition for its work in genetic engineering, over and above its ongoing pursuit to produce commercially viable spider silk.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Establishes Value Beyond Spider Silk

Thursday, July 16th, 2009

Kraig Biocraft Laboratories, Inc., the biotech company currently using genetic modification of silkworms in an effort to produce spider silk, is playing a leading edge role in one of today’s major scientific endeavors. The use of genetic engineering to modify life forms for the production of unique proteins promises to change the world of materials and research, allowing us to effectively customize what we work with. Though Kraig Biocraft has gained much exposure for its progress in the pursuit of spider silk, it is increasingly being recognized for its developments in the implementation of genetic engineering.

Proteins are a key element of living things, and can come in an almost endless variety, each having a unique set of properties that can be used in research, pharmaceuticals, and materials. But specific proteins can be very difficult to come by, especially in the volumes required for different applications. Proteins are produced by genes, which provide the coded recipes for the various proteins. Most of the proteins scientists want occur in nature, but seldom in the quantities needed. Genetic engineering can help solve the supply problem.

By isolating and analyzing the genes that produce the desired proteins, scientists can identify the specific chemical formula of the genes, called gene sequencing, allowing them to replicate the genes. Knowing how to replicate a gene means you are no longer dependent upon nature as its source. However, in order to actually make and operate a functional gene, you still need a host organism. Bacteria are frequently used as genetic host organisms. Re-created genetic material from the original organism is introduced into the host organism, using advanced genetic engineering techniques, allowing the host organism to now produce the corresponding proteins, called protein expression.

It’s not an easy process. First of all, scientists don’t yet know all of the genetic codes available in nature. And, once known, it can be difficult to find an appropriate host and develop the sophisticated techniques required to introduce the genetic material into the host. Kraig Biocraft Laboratories is one of the companies in the forefront of this field. Utilizing the silkworm as the genetic host, and introducing isolated spider genes, the company is closing in on the economically viable production of spider silk, something that has never before been accomplished.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories Inc. (KBLB.OB) and Team of Scientists Successfully Create 8 Spider Silk-Based DNA Constructs

Monday, July 13th, 2009

Kraig Biocraft Laboratories Inc. develops protein-based fiber using recombinant DNA technology. The company focuses on spider silk because of its exceptional strength and durability. Some spiders produce up to seven different types of silk, depending on its use, for catching prey, spinning a web, or traveling.

Since spiders are cannibals and hard to keep in colonies, the company maintains its focus on reproducing the fibers using transgenic silkworms. The idea is to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar or an exact copy of natural spider silk, which is can be used in military and police departments, industrial and consumer applications, as well as for the aero-space industry.

In May of this year, Kraig Biocraft announced that it has successfully created eight DNA constructs, with the help of a team of scientists. Having teamed up with the University of Notre Dame to move into the $92 billion market for technical fibers, the news is a milestone for the company and the university.

“These constructs include a number of new DNA combinations that are truly exciting,” said CEO Kim K. Thompson. “The increases in laboratory productivity over the last eight months are now enabling us to do more and to do it faster. This number of unique genetic constructs is a new breakthrough for the company. Each of these constructs has the potential to result in the development of a new polymer or high performance fiber.”

In layman’s terms, the genetic constructs are packets of DNA that act as a blueprint for the creation of new polymers and spider silk-based proteins. According to the company and participating scientists, the experiments have increased dramatically.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Aiming for Multi-Million Dollar Fiber

Wednesday, July 8th, 2009

Kraig Biocraft Laboratories Inc. is a biotechnology company pursuing a unique protein expression system with the goal of producing a new generation of technical fibers. The company is making use of state of the art genetic techniques in order to develop a transgenic silkworm capable of producing spider silk.

Specifically, the company is aiming towards a sub-sector of the “technical textiles” market known as the high-performance fibers market. All of the products in this area are significantly stronger than steel of the same weights and diameters. Due to this superior strength and toughness, these fibers have been widely adopted into a variety of industrial applications.

The high-performance fibers market can be broken down into two main areas. The first of these areas is aramid fibers. The best known of these fibers is DuPont’s Kevlar, which holds a significant share of this market and produces over $5 billion in sales for DuPont. Kevlar’s very high strength and lightweight qualities have allowed it to dominate this market for over four decades.

The second classification of high-performance fibers is ultra-high molecular weight polyethylene fibers. An example of this type of product is Spectra, which is produced by Honeywell. Spectra has applications for use in bullet resistant vests, helmets, armored vehicles, and marine-related applications.

Another example is Dyneema, which is produced by Dutch firm DSM NV. Dyneema is an important component in ropes, cables and nets used in fishing, shipping and offshore industries due to its ultra-high strength, resistance to moisture and ability to float in water.

The worldwide market for these types of fibers is estimated to be about $90 billion. This market has grown rapidly over the past 10 years and is expected to sustain a rapid growth rate going forward. Despite the formidable competition, Kraig Biocraft is expected to carve out a profitable niche in the market with spider silk products.

Spider silk has some distinct advantages over synthetically derived products. For example, spider silk is unmatched by any man-made or natural product when it comes to its ability to absorb energy prior to fiber breakage. And obviously, spider silk is a natural product, not made with toxic chemicals, and it is biodegradable. If Kraig Biocraft is successful, they will have a unique product worth at least several hundred million dollars.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Utilizing Latest Genetic Technology in Search of Super-Fiber

Monday, July 6th, 2009

Kraig Biocraft Laboratories Inc. is a company focused on the development of high performance technical fibers and polymers utilizing spider genes for insertion into silkworms. The idea is to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar or an exact copy of natural spider silk, which is one of the strongest and most resilient fibers known.

Kraig Biocraft has acquired the exclusive rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is also working in conjunction with leading genetic engineers at these universities toward the goal of producing a transgenic variety of silkworms.

While the production of a “super fiber” is the primary focus of Kraig Biocraft at this time, the company is also considering the production of other unique proteins utilizing transgenic silkworms as a unique protein expression platform. There is thought to be a large, viable market for these unique proteins within the pharmaceutical, biotechnology and other research driven industries.

As part of the company’s intellectual property portfolio, Kraig Biocraft has the exclusive rights to use the patented spider silk gene sequences in silkworms within the United States. The company’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. It is expected that Kraig Biocraft’s intellectual property portfolio will continue to grow over the coming years.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Anticipates Success

Thursday, July 2nd, 2009

Emerging biotech company, Kraig Biocraft Laboratories, Inc. was founded by the inventor of the company’s technology, current chief executive officer, Kim Thompson. The company is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. As of last report, there are about 501 million common shares outstanding, with approximately 64% held by the chief executive officer.

Kraig Biocraft Laboratories’ CEO serves as the overall coordinator for the company relative to business operations and ongoing research and development. Several prominent genetic scientists have significantly developed the companies’ technologies. Additionally, the laboratory staffs of these professors are also making significant contributions to the company’s efforts.

Kraig Biocraft Laboratories, Inc. has a developed intellectual portfolio relating to the harvesting of silk from genetically modified silkworms. The company brings together preeminent researchers in a collaborative effort to produce commercially significant quantities of spider silk, one of the world’s strongest and most resilient fibers.

In order to achieve this goal, the company has aligned itself with teams from the University of Notre Dame and the University of Wyoming, two leading research universities. The project includes Dr. Malcolm Fraser of Notre Dame, a noted genetic scientist and a member of the first team of researchers to develop a transgenic silkworm, and Dr. Randy Lewis of the University of Wyoming, one of the world’s foremost authorities on spider silk. The University of Wyoming, which holds significant intellectual property rights relating to the genetic sequencing of spiders, is a meaningful equity investor in the company.

Efforts to produce the desired proteins in a transgenic silkworm have significantly accelerated over the past several months, possibly leading to a breakthrough in the laboratory by the end of this year. The perfected technology required for the project is expected to arrive a year following the breakthrough.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Has Significant Addition to the Research Team

Friday, June 26th, 2009

Kraig Biocraft Laboratories Inc. is an emerging biotech company with a strong intellectual property portfolio relating to the genetic modification of silkworms to produce spider silk. The company believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications. With spider silk as a base, the company hopes to tap into the $92 billion market for high performance and technical fibers.

Kraig Biocraft announced several months ago that genetic engineer Dr. Bong-Hee Sohn joined the research and development team to develop new high performance polymers using spider silk gene sequences. Dr. Sohn is another major addition to the research team at the company.

Dr. Sohn received her PhD from Kyung-Hee University in South Korea. Her extensive research background includes work in research labs in Japan and South Korea. One of her areas of specialty in genetic engineering is the development of novel methods for transgenic silkworm production.

Kraig Biocraft’s CEO Kim Thompson said that “Dr. Sohn has already made a significant impact on the pace and direction of our development program. This is a very exciting time for the company and for the research laboratory.”

Mr. Thompson went on “The University of Notre Dame hired Dr. Sohn to work on specific applications of genetic engineering in silkworms for polymer development and protein expression platform technologies, which are the company’s major area of focus. The company is now fully on target for significantly accelerating the pace of its R & D.”

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Continues To Grow Strong Intellectual Property Portfolio

Wednesday, June 17th, 2009

Kraig Biocraft Laboratories, Inc., an emerging biotech company with an already strong intellectual property portfolio relating to the genetic modification of silkworms to produce spider silk, continues to strengthen its position as it develops faster and more efficient research methodologies.

The company describes its technology as a unique protein expression system that is potentially highly scalable and cost effective in producing a variety of proteins that can be marketed to the pharmaceutical and fibers markets, although spider silk remains the principal goal of the company. Kraig Biocraft has successfully inserted into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk, but work remains to be done for the actual production of spider silk.

Spider silk has elasticity and strength properties unmatched by any man-made fiber, including DuPont’s Kevlar, the most successful synthetic technical fiber ever produced, which pales in comparison to spider silk in the ability to absorb energy prior to fiber breakage. An additional advantage of spider silk is that it is derived from natural sources and is biodegradable, unlike competitive products which are manufactured using toxic and polluting chemicals. The only thing required by genetically modified silkworms is oxygen and Mulberry leaves.

And all of these spider silk qualities come in a package that is unbelievably lightweight. A strand of spider silk stretching all the way around the globe would amount to no more than a pound or two. This strand would be five times the strength of steel of the same diameter.

With these unparalleled attributes, the market possibilities for spider silk are almost countless, with a dollar value in the billions. It is estimated that DuPont pulls in well over $5 billion annually in sales of Kevlar, and the overall high performance technical fibers market is currently around $90 billion annually.

So it’s fairly conservative to predict that, should Kraig Biocraft be able to develop a commercially viable transgenic species capable of producing spider silk proteins, the discovery would immediately be worth several hundred million dollars to one of the multinational corporations involved in the technical textiles industry.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB): The New Silk Road

Monday, June 15th, 2009

Take a minute, close your eyes, and think back to when you were in the 7th grade. At some point your geography or history teacher was probably talking to you about Marco Polo and something called the Silk Road. The Silk Road, actually a network of roads and sea routes connecting China to the Mediterranean, and ultimately to Europe, was a conduit for trade until the 15th century. Gold and silver were carried eastward to China and in return traders going back west carried something that was, pound for pound, far more valuable than even gold. They carried what was for thousands of years one of China’s major exports, natural silk, the product of a lowly caterpillar.

The reason for silk’s hold on people is, of course, its unique properties. A smooth and luxurious fiber, it can be dyed and printed in striking bright colors. It also ranks high in strength for natural fibers. Of course the silkworm isn’t the only thing that produces silk. It has been said spiders were producing silk long before silkworms even existed. In fact, spider silk has certain properties superior even to silkworm silk, such as tensile strength and the unparalleled capacity to absorb energy and dissipate it in a very controlled manner. So, why was spider silk not produced and traded?

To produce silk in volume, you need a concentrated production environment. Imagine thousands of silk worms living and working next to each other. As it turns out, spiders don’t . . . well let’s just say they don’t play well together. In fact, they tend to eat each other, which of course is not good for production. So, although people have long wanted to produce spider silk, there was no effective way to do it. What they needed was some way of combining the unique qualities of spider silk and the production capabilities of the silkworm.

Well now, for the first time in history, genetic engineering is giving us the possibility of doing just that. Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) is developing a way of actually inserting spider silk DNA directly into silkworms, allowing the silkworms to produce the proteins for spider silk. The result, it is hoped, will be the mass production of spider silk, including its tremendous tensile strength. Stronger than steel by weight, spider silk could conceivably jump to dominance in the high performance fiber market, a market worth billions, with current leaders including:

Dupont (NYSE: DD)
Honeywell (NYSE: HON)
Cytec Industries (NYSE: CYT)
Hexcel Corp. (NYSE: HXL

If Kraig Biocraft is successful, it will represent a new way of getting silk; perhaps the biggest breakthrough in silk production in a thousand years. With the company’s leading team of scientific experts and breakthroughs taking place in the lab, the world is closer than ever to experiencing the many benefits offered by this exciting technology.

 Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB): Big Rewards from Small Players

Friday, June 12th, 2009

Dividends are often regarded as a key indicator of a company’s financial health. They also contribute significantly to a stock investor’s long-term wealth, making them a crucial factor in evaluating a company for long-term investment. In today’s economic climate, it’s even more important to build a portfolio of quality companies with the financial strength necessary to issue dividends.

A recent research study found that in the year large-cap companies first began paying dividends, or reinstated them after a lapse, they outperformed their peers by 2.7 percentage points. However, large-cap stocks aren’t the only ones that issue dividends. Small-cap and Micro-cap companies also issue various types of dividends to reward existing investors as well as attract new investors.

Although the dividend payable dates for these companies have passed, some of the recently announced micro-cap dividends include Cadence Financial Corp.’s (NASDAQ: CADE) cash dividend of $0.05; Crosstex Energy, Inc.’s (NASDAQ: XTXI) $0.09 dividend; and Unilens Vision Inc.’s $0.09 cash dividend. Companies that have upcoming dividend payable dates include Ecology and Environment, Inc.’s $0.20 six-month dividend that will be paid on or before August 7, 2009; First Keystone Corp.’s (OTCBB: FKYS) $0.23 stock dividend to be paid on June 30, 2009; and James Financial Group, Inc.’s 5% stock dividend that is payable on July 21, 2009.

One of the companies we’re watching closely that recently approved a stock dividend is Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB). The development-stage biotechnology company is focused on tapping the $92 billion market for high performance polymers and technical fibers. Kraig Biocraft has made significant progress in their labs over the past few months and is closer than ever to finding a solution for producing commercial quantities of spider silk, a super-strength fiber that has an unparalleled capacity to absorb energy and dissipate it in a very controlled manner.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Scientific Based Efforts have Extraordinary Potential

Thursday, June 11th, 2009

Kraig Biocraft Laboratories’ prospects to develop a “super fiber” that can be sold into the technical textiles industry are exciting. The company’s research and development efforts are based on solid science that has been developed by some of the world’s leading genetic researchers. Kraig Biocraft is moving ever closer to the successful production of transgenic species to produce commercial quantities of spider silk.

The physical properties of spider silk are quite remarkable and commercial production of these fibers will be viewed as a major breakthrough by the scientific community. Such a development would likely yield significant coverage in the general business and popular press sectors, offering Kraig Biocraft Laboratories significant public relations exposure, which could push the price of its shares to much higher levels.

One of the major hurdles that most biotechnology companies must overcome is the FDA approval process. Fortunately for Kraig Biocraft, their technology doesn’t have to be approved by the FDA, which makes it much easier for investors to monetize their investment since the costs are significantly reduced and the time to market is much shorter. The potential for success is also much greater as only 5 out of 5,000 compounds discovered in the pre-clinical stage ever make it through the entire FDA approval process.

Should Kraig Biocraft achieve its goal of creating transgenic silkworms capable of expressing significant amounts of spider silk proteins, the technology is estimated to be immediately worth at least several hundred million dollars. Further refinement of the technology and initial acceptance by the technical textiles market could potentially yield an overall value for this technology in excess of $1 billion. With so much incredible potential, there’s no reason the company shouldn’t be on your radar.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Looking to Spin New “Super-Fiber”

Tuesday, June 9th, 2009

Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working directly in conjunction with leading genetic engineers at these universities to develop transgenic silkworms.

Kraig Biocraft’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. The company expects this intellectual property portfolio to expand over the coming years.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Recognizes Discovery to Enhance Spider Silk Strength

Thursday, June 4th, 2009

Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development of commercially significant high performance polymers and technical fibers. Based on proprietary genetic engineering technology, the company is working to develop and produce polymers and protein-based materials from silkworms and spiders. Kraig Biocraft believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications.

Kraig Biocraft recently announced that scientists have discovered a way to make spider silk three times stronger by adding small amounts of metal. Even though the natural spider-made fiber is already tougher and lighter than steel, this new technique could make it useful for manufacturing super-tough textiles and high-tech medical materials, such as artificial bonds and tendons.

The discovery, published by the journal “Science”, was made by researcher Seung-Mo Lee of the Max Planck Institute of Microstructure Physics in Halle, Germany. The breakthrough addition of zinc, aluminum or titanium to a length of spider silk made it more resistant to breaking or deforming, effectively making the strand three times stronger.

Kraig Biocraft CEO Kim Thompson stated, “This new discovery is absolutely incredible. Spider silk is already known as one of the strongest fibers found in nature and is recognized for its unparalled capacity to absorb and dissipate energy in a very controlled manner. Being five times stronger than steel of the same diameter in its natural form, this enhancement reminds us again of the extraordinary potential spider silk has. Kraig Biocraft Laboratories is committed to continuing to develop sustainable spider silk for commercial use worldwide.”

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Kraig Biocraft Laboratories, Inc.’s (KBLB.OB) Target Market

Tuesday, June 2nd, 2009

The market Kraig Biocraft Laboratories has targeted is commonly referred to as the “technical textiles” market. This market encompasses a wide range of products that are used for a large number of different types of applications. The products sold into the technical textiles market are either finished products in themselves or are used as components to produce other products.

The specific sector of the technical textiles market targeted by Kraig Biocraft is known as the high-performance fibers market and can be broken down into two main areas: Aramid fibers, the best known of these fibers being DuPont’s Kevlar which produces more than $5 billion in annual sales; and ultra-high molecular weight polyethylene fibers, such as Spectra, which is produced by Honeywell International, Inc.

The worldwide market for these fibers and other high performance technical fibers is massive. It is estimated that this market generates $90 billion per year, with the United States accounting for more than half of the market. The industry has experienced significant growth over the past 10 years and is expected to continue growing at a similarly robust rate over the coming years.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board